As workout studios close their doors amid a global pandemic, people are left with one of the cheapest and easiest ways to break a sweat: running.
But just because you know you could be running, doesn’t mean you’ll actually go out and jog. That’s where a new Nike-funded research team comes in. They want to help people struggling to go the distance — and invented a wearable ankle “exoskeleton” that makes running 14 PERCENT EASIER AND ENERGY-EFFICIENT compared to normal running shoes.
There is a huge public debate whether the economic costs of actions designed to arrest the spread of COVID-19 are worth the potential health benefits achieved.
Literally trillions of dollars in lost economic output and uncounted lives hang in the balance. No rational discussion of this weighty issue is possible without first having a hard-nosed discussion of the dollar value of saving the lives of COVID-19 patients.
This post will focus on the well-established methods that health economists have devised to answer this question.
Times of upheaval are always times of radical change. Some believe the pandemic is a once-in-a-generation chance to remake society and build a better future. Others fear it may only make existing injustices worse.
Everything feels new, unbelievable, overwhelming. At the same time, it feels as if we’ve walked into an old recurring dream. In a way, we have. We’ve seen it before, on TV and in blockbusters. We knew roughly what it would be like, and somehow this makes the encounter not less strange, but more so.
Every day brings news of developments that, as recently as February, would have felt impossible – the work of years, not mere days. We refresh the news not because of a civic sense that following the news is important, but because so much may have happened since the last refresh. These developments are coming so fast that it’s hard to remember just how radical they are.
Futurist Thomas Frey has predicted that drones will become the most disruptive technology in human history. In a quiet residential neighborhood in Christiansburg, Virginia., one happens to be disrupting the work of two landscapers.
The workers silence their weed eaters, looking to the sky in wonder as the whining drone slows, descends, steadies, then hovers about 23 feet above the front yard of Paul and Susie Sensmeier, two retirees in their eighties.
The drone carries a three-pound plastic package, attached by a cord and a hook. It lowers the package until it softly touches down on the turf. The hook detaches, the line is reeled back in, and the craft zooms off into the horizon at 70 mph.
“There’s been no complaints that I know of from the neighborhood, and there’s quite a few customers that live here,” says Paul, a retired engineer who knows a thing or two about innovations in technology. His son works as an aerospace engineer, and his son-in-law is a researcher at the nearby Virginia Tech Transportation Institute. “It is the wave of the future, and it’s exciting to be a part of the developmental process.”
At present, 170 countries are affected by the pandemic, COVID-19. The rate of infection continues to rise fivefold on a daily basis across the world, and the data continues to highlight the transnational force of contagion. To date, there is no unifying or effective method to treat the disease or its spread, which would need the capacity to reach and save an estimated 5.3 billion people who are expected to contract the illness in the coming months.
The COVID- 19 pandemic we face currently is an important reminder of the power of infectious diseases.
But, in the midst of all this doom and gloom, the COVID-19 pandemic has highlighted some important lessons for the global health sector. It offers a critical insight into how innovation and advanced technology may better equip and support us as we tackle this global pandemic and handle public health emergencies to contain, mitigate and eradicate the spread of infectious diseases globally.
Yesterday, Swoop Aero took a leading role in global health transformation. We became the first drone logistics company globally to operate a fleet of aircraft from outside the country of operation. We have deployed this capability in order to support the Malawian national government’s health system as they commence their response to the pandemic. With the backing of the College of Medicine and the Malawian Department of Civil Aviation, our ground operations teams, staffed by local Malawians that have been trained over the last few months, made this possible. There were no members of the Australian flight operations team present, as they have all returned to Australia to comply with the government’s strict travel restrictions. The goal of this remotely piloted operation is to support the government’s COVID-19 response following reports of an acceleration of reported cases across the country. It means that our local Malawian ground operations teams are not losing their jobs at a difficult time for the economy. In addition, at a time when normality has been suspended for most, this means that we can continue routine flight operations in our network, delivering essential healthcare supplies for pre-existing communicable diseases, such as HIV/AIDS, malaria and TB.
Traditional change management as we know it is obsolete. Even the very notion that change can be managed feels absurd given the reality and pace of business today. The intent of business executives—to deliver results more sustainably and more quickly—remains the same, but the context in which organizations operate today is fundamentally shifting, and so is the way in which we should think about change.
When will SpaceX’s first manned flight launch? No earlier than mid-to-late May, the company declared via its Twitter account Wednesday. The “Demo–2” Crew Dragon flight will see astronauts Robert Behnken and Douglas Hurley fly to the International Space Station. A successful mission will enable SpaceX to send NASA astronauts to the space station, giving the agency a new means of ferrying crew.
A cell, in greenish brown, heavily infected with coronavirus particles, in pink.
Such a test may help scientists learn how widespread the infection is, and how long people remain immune after recovering.
A cell, in greenish brown, heavily infected with coronavirus particles, in pink.Credit…Niaid, via Reuters
The Food and Drug Administration on Thursday approved a new test for coronavirus antibodies, the first for use in the United States.
Currently available tests are designed to find fragments of viral genes indicating an ongoing infection. Doctors swab the nose and throat, and amplify any genetic material from the virus found there.
The Federal Communications Commission has approved SpaceX’s application to roll out a million user terminals in the US to connect with its growing Starlink satellite broadband network.
The approval gives SpaceX a 15-year “blanket license for the operation of up to 1,000,000 fixed earth stations that will communicate with its non-geostationary orbit satellite system”.
Graphene-based biosensors could usher in an era of liquid biopsy, detecting DNA cancer markers circulating in a patient’s blood or serum. But current designs need a lot of DNA. In a new study, crumpling graphene makes it more than ten thousand times more sensitive to DNA by creating electrical “hot spots,” researchers at the University of Illinois at Urbana-Champaign found.
Crumpled graphene could be used in a wide array of biosensing applications for rapid diagnosis, the researchers said. They published their results in the journal Nature Communications.
“This sensor can detect ultra-low concentrations of molecules that are markers of disease, which is important for early diagnosis,” said study leader Rashid Bashir, a professor of bioengineering and the dean of the Grainger College of Engineering at Illinois. “It’s very sensitive, it’s low-cost, it’s easy to use, and it’s using graphene in a new way.”
Old human cells can become more youthful by coaxing them to briefly express proteins used to make induced pluripotent cells, Stanford researchers and their colleagues have found. The finding may have implications for aging research.
Old human cells return to a more youthful and vigorous state after being induced to briefly express a panel of proteins involved in embryonic development, according to a new study by researchers at the Stanford University School of Medicine.
The researchers also found that elderly mice regained youthful strength after their existing muscle stem cells were subjected to the rejuvenating protein treatment and transplanted back into their bodies.
The proteins, known as Yamanaka factors, are commonly used to transform adult cells into induced pluripotent stem cells, or iPS cells. Induced pluripotent stem cells can become nearly any type of cell in the body, regardless of the cell from which they originated. They’ve become important in regenerative medicine and drug discovery.
Right now the world is at war. But this is no ordinary war. It’s a fight with an organism so small we can only detect it through use of a microscope — and if we don’t stop it, it could kill millions of us in the next several decades. No, I’m not talking about COVID-19, though that organism is the one on everyone’s mind right now. I’m talking about antibiotic-resistant bacteria.
You see, more than 700,000 people died globally from bacterial infections last year — 35,000 of them in the U.S. If we do nothing, that number could grow to 10 million annually by 2050, according to a United Nations report.
The problem? Antibiotic overuse at the doctor’s office or in livestock and farming practices. We used a lot of drugs over time to kill off all the bad bacteria — but it only killed off most, not all, of the bad bacteria. And, as the famous line from Jeff Goldblum in Jurassic Park goes, “life finds a way.”
Enter Felix, a biotech startup in the latest Y Combinator batch that thinks it has a novel approach to keeping bacterial infections at bay – viruses.
